These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 38497450)
21. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. Flockerzi A; Ruggieri A; Frank O; Sauter M; Maldener E; Kopper B; Wullich B; Seifarth W; Müller-Lantzsch N; Leib-Mösch C; Meese E; Mayer J BMC Genomics; 2008 Jul; 9():354. PubMed ID: 18664271 [TBL] [Abstract][Full Text] [Related]
22. Human endogenous retrovirus type K encoded Np9 oncoprotein induces DNA damage response. Chen J; Fan J; Lin Z; Dai L; Qin Z J Med Virol; 2024 Mar; 96(3):e29534. PubMed ID: 38501356 [TBL] [Abstract][Full Text] [Related]
24. Hypermutation of an ancient human retrovirus by APOBEC3G. Lee YN; Malim MH; Bieniasz PD J Virol; 2008 Sep; 82(17):8762-70. PubMed ID: 18562521 [TBL] [Abstract][Full Text] [Related]
25. Human endogenous retroviruses in cancer: Oncogenesis mechanisms and clinical implications. Kitsou K; Lagiou P; Magiorkinis G J Med Virol; 2023 Jan; 95(1):e28350. PubMed ID: 36428242 [TBL] [Abstract][Full Text] [Related]
26. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors. Contreras-Galindo R; Dube D; Fujinaga K; Kaplan MH; Markovitz DM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931682 [TBL] [Abstract][Full Text] [Related]
27. Human endogenous retroviruses and cancer. Gonzalez-Cao M; Iduma P; Karachaliou N; Santarpia M; Blanco J; Rosell R Cancer Biol Med; 2016 Dec; 13(4):483-488. PubMed ID: 28154780 [TBL] [Abstract][Full Text] [Related]
28. Expression of Human Endogenous Retrovirus Group K (HERV-K) HML-2 Correlates with Immune Activation of Macrophages and Type I Interferon Response. Russ E; Mikhalkevich N; Iordanskiy S Microbiol Spectr; 2023 Mar; 11(2):e0443822. PubMed ID: 36861980 [TBL] [Abstract][Full Text] [Related]
29. Identification and Characterization of the HERV-K (HML-8) Group of Human Endogenous Retroviruses in the Genome. Liu M; Jia L; Guo X; Zhai X; Li H; Liu Y; Han J; Zhang B; Wang X; Li T; Wang Y; Li J; Yu C; Li L AIDS Res Hum Retroviruses; 2023 Apr; 39(4):176-194. PubMed ID: 36656667 [TBL] [Abstract][Full Text] [Related]
30. Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target. Curty G; Marston JL; de Mulder Rougvie M; Leal FE; Nixon DF; Soares MA Viruses; 2020 Jul; 12(7):. PubMed ID: 32640516 [TBL] [Abstract][Full Text] [Related]
31. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes. Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457 [TBL] [Abstract][Full Text] [Related]
32. Human endogenous retroviruses and cancer prevention: evidence and prospects. Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240 [TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis. Garson JA; Usher L; Al-Chalabi A; Huggett J; Day EF; McCormick AL Acta Neuropathol Commun; 2019 Mar; 7(1):45. PubMed ID: 30885274 [TBL] [Abstract][Full Text] [Related]
34. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells. Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642 [TBL] [Abstract][Full Text] [Related]
35. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267 [TBL] [Abstract][Full Text] [Related]
36. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Wang-Johanning F; Li M; Esteva FJ; Hess KR; Yin B; Rycaj K; Plummer JB; Garza JG; Ambs S; Johanning GL Int J Cancer; 2014 Feb; 134(3):587-95. PubMed ID: 23873154 [TBL] [Abstract][Full Text] [Related]
37. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571 [TBL] [Abstract][Full Text] [Related]
38. Human endogenous retroviruses and the inflammatory response: A vicious circle associated with health and illness. Rangel SC; da Silva MD; da Silva AL; Dos Santos JMB; Neves LM; Pedrosa A; Rodrigues FM; Trettel CDS; Furtado GE; de Barros MP; Bachi ALL; Romano CM; Nali LHDS Front Immunol; 2022; 13():1057791. PubMed ID: 36518758 [TBL] [Abstract][Full Text] [Related]
39. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309 [TBL] [Abstract][Full Text] [Related]
40. Genomic flexibility of human endogenous retrovirus type K. Dube D; Contreras-Galindo R; He S; King SR; Gonzalez-Hernandez MJ; Gitlin SD; Kaplan MH; Markovitz DM J Virol; 2014 Sep; 88(17):9673-82. PubMed ID: 24920813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]